TrialThe New England journal of medicine2018
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
Luis Paz-Ares et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2,115 papers cite itlatest 60 shown
this paperpooled ittrialcites it